$CDLX

Cardlytics (CDLX) Q2 2026 Earnings Call Transcript

Cardlytics (CDLX) reported Q2 2026 results on an earnings call. Revenue was $36.9M, down 36% YoY, with billings $65.5M (-34%) and adjusted contribution $21.3M (-32%). Net loss was $14.9M. Q3 2026 guidance: billings $61M-$67M, revenue $34M-$39M, adjusted EBITDA $0M-$3M. Cash was $28M.

Original reporting
Published Aug 13, 2026, 1:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 2:18 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cardlytics (CDLX) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$CDLXBearishMed
01

Why it matters

Q2 results show continued YoY contraction in revenue, billings, and monthly qualified users due to previously announced financial institution partner relationship changes. Management also provided Q3 2026 guidance ranges and emphasized cost containment, free cash flow focus, and AI integration to improve campaign efficiency.

02

Market read

Traders will likely reprice near-term expectations around billings and revenue durability after partner resets, while monitoring whether improved advertiser metrics translate into revenue stabilization.

03

What to watch

The call highlights AI-driven campaign publishing time reduction and a Monzo partnership expansion, which could improve monetization efficiency even while MQUs and revenue remain down.

Relevance 8/10Novelty 8/10Timing: post-market earnings call, guidance for Q3 2026 disclosed

Background

Cardlytics is a digital advertising and rewards platform that relies on bank partner relationships and transaction data to target and measure campaigns.

Company-level read

Ticker impact

$CDLXBearishMedium confidence
Context

Cardlytics reported Q2 2026 revenue of $36.9M, down 36% YoY, and guided Q3 billings $61M to $67M amid partner resets.

Expected impact

Near-term downside bias versus prior expectations, with traders likely focusing on whether Q3 ranges stabilize after the bank-partner relationship changes.

Evidence & confidence

Multiple concurrent negatives (revenue, MQUs, net loss, operating cash flow) are paired with guidance that is only modestly below Q2 billings at the midpoint, suggesting continued pressure rather than a clear inflection.

Market effects

Signals ongoing stress in performance marketing tied to bank-partner data access, with cost containment and AI tooling as the main offset.

UK revenue growth over 10% YoY is a relative bright spot that may support regional sentiment for similar fintech-advertising models.

Limited direct global spillover beyond the digital rewards and purchase-intelligence niche.

Counterpoint

Advertiser churn and new logo volume improved materially, implying the revenue decline may be more about partner restructuring timing than underlying demand collapse.

Key entities

  • Cardlytics, Inc.

    Reported Q2 2026 results and provided Q3 2026 guidance, with ongoing declines tied to bank partner relationship restructuring.

  • Amit Gupta

    CEO who discussed rewards model shifts and AI-driven campaign publishing efficiency.

  • David Evans

    CFO who discussed guidance ranges and the timing of anniversarying partner relationship changes.

  • Monzo

    Expanded partnership in July 2026 to power personalized spend-based cashback rewards in the UK.

Related articles

$CDLXMedAI 8/10

Cardlytics: Q2 Earnings Snapshot

Cardlytics (CDLX) reported a Q2 loss of $14.9 million, or $2.58 per share. Adjusted for discontinued operations, the loss was $1.50 per share. Revenue was $36.9 million. For the quarter ending September, the company expects revenue of $34 million to $39 million.

$CDLXMed

Cardlytics, Inc. (CDLX): Results of Operations and Financial Condition

Cardlytics, Inc. (CDLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance • Company delivers strong second quarter results: ◦ Revenues of $36.9 million ◦ Billings of $65.5 million ◦ Adjusted Contribution of $21.3 million ◦ Net Loss of $(14.9) million

$EQIXMedAI 8/10

Equinix Is Doubling Down on AI Data Centers. How to Play EQIX Stock Here

Equinix (EQIX) reported Q2 revenue of $2.63B, up 16% YoY, beating estimates. AFFO was $11.78/share, up 19% YoY. The company raised full-year guidance and unveiled a multi-year growth plan. EQIX stock has surged 34% over the past year and offers a 1.98% dividend yield. Analysts rate it a 'Strong Buy' with an average price target of $1,232.19.

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.

$ORCLMedAI 8/10

Oracle’s AI Earnings Story Is Improving, but the Cash Flow Test Remains

Oracle (ORCL) reported strong Q4 earnings with 21% revenue growth and raised its profit forecast. Morgan Stanley increased its price target to $210, citing improved GPUaaS margins. However, the company faces cash flow pressure due to high capital expenditures for AI infrastructure, with free cash flow at negative $23.7 billion. Hedge funds remain invested, with Fisher Asset Management increasing its stake.